← All Sponsors
SPONSOR

Centessa Pharmaceuticals (UK) Limited

Total Trials
2
Recruiting
2
Phases
Phase 2
Conditions studied: Narcolepsy Type 1Narcolepsy Type 2Idiopathic Hypersomnia
NCT06752668 Phase 2
Recruiting

A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

Narcolepsy Type 1
United States, Canada View Trial →
NCT07096674 Phase 2
Recruiting

A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

Narcolepsy Type 1
United States View Trial →